Proteomic Analysis of GLUT4 Storage Vesicles Reveals Tumor Suppressor Candidate 5 (TUSC5) as a Novel Regulator of Insulin Action in Adipocytes

被引:51
作者
Fazakerley, Daniel J. [1 ,3 ]
Naghiloo, Sheyda [1 ,3 ]
Chaudhuri, Rima [1 ,3 ]
Koumanov, Francoise [4 ]
Burchfield, James G. [1 ,3 ]
Thomas, Kristen C. [1 ]
Krycer, James R. [1 ,3 ]
Prior, Matthew J. [3 ]
Parker, Ben L. [1 ,3 ]
Murrow, Beverley A. [3 ]
Stoeckli, Jacqueline [1 ,3 ]
Meoli, Christopher C. [1 ,3 ]
Holman, Geoffrey D. [4 ]
James, David E. [1 ,2 ,3 ]
机构
[1] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia
[2] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia
[3] Garvan Inst Med Res, Sydney, NSW 2010, Australia
[4] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England
基金
英国医学研究理事会;
关键词
GLUCOSE-TRANSPORTER GLUT4; CELL-SURFACE GLUT4; RAT ADIPOSE-CELLS; STIMULATED TRANSLOCATION; PROTEIN; TISSUE; BINDING; SUFFICIENT; METFORMIN; INCREASES;
D O I
10.1074/jbc.M115.657361
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin signaling augments glucose transport by regulating glucose transporter 4 (GLUT4) trafficking from specialized intracellular compartments, termed GLUT4 storage vesicles (GSVs), to the plasma membrane. Proteomic analysis of GSVs by mass spectrometry revealed enrichment of 59 proteins in these vesicles. We measured reduced abundance of 23 of these proteins following insulin stimulation and assigned these as high confidence GSV proteins. These included established GSV proteins such as GLUT4 and insulin-responsive aminopeptidase, as well as six proteins not previously reported to be localized to GSVs. Tumor suppressor candidate 5 (TUSC5) was shown to be a novel GSV protein that underwent a 3.7-fold increase in abundance at the plasma membrane in response to insulin. siRNA-mediated knockdown of TUSC5 decreased insulin-stimulated glucose uptake, although overexpression of TUSC5 had the opposite effect, implicating TUSC5 as a positive regulator of insulin-stimulated glucose transport in adipocytes. Incubation of adipocytes with TNF alpha caused insulin resistance and a concomitant reduction in TUSC5. Consistent with previous studies, peroxisome proliferator-activated receptor (PPAR) gamma agonism reversed TNF alpha-induced insulin resistance. TUSC5 expression was necessary but insufficient for PPAR gamma-mediated reversal of insulin resistance. These findings functionally link TUSC5 to GLUT4 trafficking, insulin action, insulin resistance, and PPAR gamma action in the adipocyte. Further studies are required to establish the exact role of TUSC5 in adipocytes.
引用
收藏
页码:23528 / 23542
页数:15
相关论文
共 72 条
[1]   Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents [J].
Ahuja, HS ;
Liu, S ;
Crombie, DL ;
Boehm, M ;
Leibowitz, MD ;
Heyman, RA ;
Depre, C ;
Nagy, L ;
Tontonoz, P ;
Davies, PJA .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :765-773
[2]  
[Anonymous], IEEE 8 INT S BIOM IM
[3]  
[Anonymous], COMMUN INTEGRATIVE B
[4]  
[Anonymous], DIRECT ANAL PATHWAYS
[5]  
[Anonymous], STAT BIOL HEALTH
[6]   Peroxisome proliferator-activated receptor-γ represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect [J].
Armoni, M ;
Kritz, N ;
Harel, C ;
Bar-Yoseph, F ;
Chen, H ;
Quon, MJ ;
Karnieli, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) :30614-30623
[7]   Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes - A 6-month randomized placebo-controlled dose-response study [J].
Aronoff, S ;
Rosenblatt, S ;
Braithwaite, S ;
Egan, JW ;
Mathisen, AL ;
Schneider, RL .
DIABETES CARE, 2000, 23 (11) :1605-1611
[8]   Binding of myotrophin/V-1 to actin-capping protein - Implications for how capping protein binds to the filament barbed end [J].
Bhattacharya, Nandini ;
Ghosh, Shatadal ;
Sept, David ;
Cooper, John A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (41) :31021-31030
[9]   Thiazolidinediones, like metformin, inhibit respiratory complex I -: A common mechanism contributing to their antidiabetic actions? [J].
Brunmair, B ;
Staniek, K ;
Gras, F ;
Scharf, N ;
Althaym, A ;
Clara, R ;
Roden, M ;
Gnaiger, E ;
Nohl, H ;
Waldhäusl, W ;
Fürnsinn, C .
DIABETES, 2004, 53 (04) :1052-1059
[10]   Novel Systems for Dynamically Assessing Insulin Action in Live Cells Reveals Heterogeneity in the Insulin Response [J].
Burchfield, James G. ;
Lu, Jinling ;
Fazakerley, Daniel J. ;
Tan, Shi-Xiong ;
Ng, Yvonne ;
Mele, Katarina ;
Buckley, Michael J. ;
Han, Weiping ;
Hughes, William E. ;
James, David E. .
TRAFFIC, 2013, 14 (03) :259-273